Navigation Links
EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
Date:9/26/2007

With ONC National Coordinator Robert N. Kolodner, MD, on its panel, the HIMSS Electronic Health Record Vendors Association focuses on advancing

EHRs

ASHEVILLE, N.C., Sept. 26 /PRNewswire-USNewswire/ -- Building on its successful collaborative efforts to further the widespread adoption of EHRs, the HIMSS Electronic Health Record Vendors Association (EHRVA) provided an in- depth and patient-centric perspective on interoperability during the North Carolina Healthcare Information and Communications Alliance, Inc. (NCHICA) Annual Conference & Exhibition. The conference, "Cultures in Transition - Healthcare Consumers, Payers and Providers," continues in Asheville, NC, through today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070926/DCW009LOGO )

"NCHICA is pleased and honored to have EHRVA's participation in our conference for the second year," said Holt Anderson, executive director of NCHICA. "The EHRVA presentation demonstrates the real potential for improving health and care for consumers in a community where they are seen in different settings with electronic systems from competing vendors. Interoperability at this level will improve patient outcomes and safety through improved information flow and access."

About 150 attendees learned more about the EHRVA and its unified position on achieving interoperability in healthcare. Members have developed the EHRVA Interoperability Roadmap to support the nationwide goal of interoperable EHRs and provide a guide that can help other healthcare organizations and health IT vendors to follow.

During the demonstration, the audience followed the flow of a patient from home, through physician office visits, and admission to the hospital using digital health information at each step to support continuity of care. This efficient and instantaneous exchange of patient health infor
'/>"/>

SOURCE HIMSS
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. EHRVA Supports EHR Product Certification
2. IMA wants members not to do sex determination tests during pregnancy
3. Invest on gym memberships
4. Five Members Of A Family Killed
5. 12-year-old girl Accused for Murder of Three Family Members
6. Shortage Of Faculty Members At AIIMS
7. Maldives Volleyball Team Members Affected by Chickenpox
8. Family Members Most Often Source of Whooping Cough in Infants
9. G8 Members To Announce Plans To Increase HIV/AIDS Spending at Summit
10. Apollo Hospitals Collaborates With Histostem For Stem Cell Therapy
11. Apollo Hospital to collaborate with US cancer center to open new radiation therapy department
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... CosmetaLife clinical trial results could lea... ,cost-effective treatment for deep lines and wrin... Minn. (PRWEB) July 24, 2008 -- Gel-Del Technolog...e company announced that it has concluded clinical...that company officials say holds potential to be a...
(Date:7/24/2008)... The Palomino Group, a leading commercializat... announced the launch of its new Meeting Support S...tical industry. The company, based in Minneapolis,...ialization consulting services that support biotec... healthcare companies. , ...
(Date:7/24/2008).../PRNewswire-FirstCall/ --, Key Highlights, Misys...ions and is now,raising targets for the next phase...(1) of GBP492m up 6%, bringing Group operating pro... executing on its strategy and entering,into the n...orm for growth., To view the Multimedia News Rele...
(Date:7/23/2008)...ular Entities Drops to Historic Low as Pharma Comp...nerics Companies, LONDON, July 24 /PRNewswire/ --...announced the availability of the newly published ..., an indispensable reference,and business planning...orporate finance, business strategy, marketing pla...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 2Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2
...g blind and partially sighted people in the Lothia...e for the Blind (RNIB) received a ?25,000 donation...help in launching the charity's Positive Steps pro...ning for people preparing to enter employment. Th...
... for Type 2 Diabetes appears to have a twin benefi...ar under control// but also helps them to lose wei...n associate Professor with the Royal Prince Alfred...this drug has been under trial on patient voluntee...
... of teeth, do not improve the mental well being an...study//. Thousands of children have orthodontic wo...n the dental profession that braces or orthodontic...ll-being, reported the online edition of BBC News....
...cer deaths for the second consecutive year, the Am...can Health Challenge// to educate and motivate Ame... Many Americans are concerned about potentially d...t 50 percent of cancer deaths could be prevented t...
Other Medicine News:Health News:Healthy Behaviors Can Prevent at Least 50 Percent of Cancer Deaths 2
(Date:7/22/2008)...(R) Resulted in Significant, Reductions in A1C in ...thm Used, BRIDGE...the "Adjust to,Target in Type 2 Diabetes: Comparis...for Adjustment of Mealtime Insulin Glulisine" stud...tion,s (ADA) medical journal,Diabetes Care. This ...
(Date:7/22/2008)...wswire/ -- Hyperion,Therapeutics, Inc. today annou...ts Phase 1/2 clinical trial to evaluate the safety...PN-100 (formally called GT4P) versus,BUPHENYL(R) (... disorders,(UCD). The company plans to announce to..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
(Date:7/22/2008)...rsity Medical Center Based on Rosetta Ge...t Differentiates Squamous From Non-Squamous Non-Sm...s-Cell Carcinoma of the Lung With Sensitivi...s is the First CLIA Approved Test Which Leverages ...Accurate Diagnosis of Lung Cancer, REHOVOT, Israe...
(Date:7/22/2008)...ire-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX)...,enrollment of 417 osteoarthritis (OA) patients wi...ology studies in the United States, in line with,p...signed to assess the,blood pressure profile of nap... using the Ambulatory Blood Pressure Monitoring (A...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events 21808 1Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events 21808 2Nanoparticles aid bone growth 21804 1Nanoparticles aid bone growth 21804 2Courage Center Extends Nomination Deadline for 2008 Phillips Awards to July 3 21800 1Courage Center Extends Nomination Deadline for 2008 Phillips Awards to July 3 21800 2Threatened or invasive 3F Species fates identified 3631 1Threatened or invasive 3F Species fates identified 3631 2
...Northfield,Laboratories Inc. (Nasdaq: NFLD) announ...has informed the Company that the report of,the su... with,PolyHeme(R), the Company,s human-hemoglobin ...t be complete until May., About Northfield Laborat...n developing an,oxygen-carrying red blood cell sub...
...tic,benefits of adding Diovan to conventional ther...mes for,Diovan patients , , , BASEL,Switzerlan...dent,Jikei Heart Study, published today in The Lan...ng medication Diovan® to,conventional therapy ...r events and a 40% reduction in stroke. , , The ...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
The GENESIS II* Total Knee System will define the state of knee implants.
Cruciate Retaining, Posterior Stabilized and Constrained Components.
StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Medicine Products: